Esmolol for heart protection during heart attack
Part of Heart & circulation clinical trials.
This study tests if giving a fast-acting heart medication (esmolol) early through an IV can protect the heart muscle during a heart attack. It may help patients who cannot receive a standard treatment due to certain risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with a type of heart attack called ST-elevation MI within the last 8 hours.
- Your doctor chose not to give you a standard IV heart medication (metoprolol) because of risks like low blood pressure, heart failure, or other conditions.
- You must be willing to sign a consent form to take part in the study.
- You cannot have severe heart failure, a very slow heart rate (below 60 beats per minute), or low blood pressure (below 100/60).
- You cannot have asthma that is currently flaring up, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This study tests a heart-slowing medicine called esmolol (a beta-blocker) in people with septic shock and a fast heart rate. It uses ultrasound to see if the medicine is safe and helpful.
This study tests a medication called esmolol to see if it helps blood flow in tiny blood vessels under the tongue for people with septic shock. If you have a fast heart rate despite treatment, this trial may help your doctors better manage your condition.
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
This study tests whether a medicine called esmolol (a beta-blocker) can help your heart recover while you are on a heart-lung machine (V-A ECMO). It is for adults with severe heart failure who are already on certain heart medicines.
Hear when a new Coronary Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.